1. Home
  2. CANF vs WLDS Comparison

CANF vs WLDS Comparison

Compare CANF & WLDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Can-Fite Biopharma Ltd Sponsored ADR (Israel)

CANF

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

HOLD

Current Price

$3.09

Market Cap

6.0M

Sector

Health Care

ML Signal

HOLD

Logo Wearable Devices Ltd.

WLDS

Wearable Devices Ltd.

HOLD

Current Price

$0.82

Market Cap

5.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CANF
WLDS
Founded
1994
2014
Country
Israel
Israel
Employees
N/A
44
Industry
Biotechnology: Pharmaceutical Preparations
Computer Communications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
6.0M
5.5M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
CANF
WLDS
Price
$3.09
$0.82
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$50.00
N/A
AVG Volume (30 Days)
18.8K
1.3M
Earning Date
03-26-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2,715,455.50
N/A
Revenue Next Year
$101.06
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.17
$0.64
52 Week High
$10.40
$11.40

Technical Indicators

Market Signals
Indicator
CANF
WLDS
Relative Strength Index (RSI) 47.27 45.41
Support Level $2.87 $0.73
Resistance Level $3.24 $1.08
Average True Range (ATR) 0.15 0.13
MACD -0.01 0.01
Stochastic Oscillator 40.66 13.88

Price Performance

Historical Comparison
CANF
WLDS

About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.

About WLDS Wearable Devices Ltd.

Wearable Devices Ltd develops and sells human-machine interface solutions for the smart wearables industry. These digital devices include consumer electronics, smart watches, smartphones, AR glasses, VR headsets, televisions, PCs, laptop computers, drones, robots, etc. The company has completed the transition phase from research and development to commercialization of technology into B2B and B2C products. Its products include Mudra Inspire, a band for the Apple Watch that allows touchless operation and control of Apple ecosystem devices such as iPhone, Mac computer, Apple TV, and iPad, inter alia.

Share on Social Networks: